|
US2699808A
(en)
|
1944-10-06 |
1955-01-18 |
Mark W Lowe |
Apparatus for peeling tomatoes
|
|
US2699508A
(en)
|
1951-12-21 |
1955-01-11 |
Selectronics Inc |
Method of mounting and construction of mounting for low frequency piezoelectric crystals
|
|
US5118800A
(en)
|
1983-12-20 |
1992-06-02 |
California Institute Of Technology |
Oligonucleotides possessing a primary amino group in the terminal nucleotide
|
|
FR2567892B1
(fr)
|
1984-07-19 |
1989-02-17 |
Centre Nat Rech Scient |
Nouveaux oligonucleotides, leur procede de preparation et leurs applications comme mediateurs dans le developpement des effets des interferons
|
|
US5166315A
(en)
|
1989-12-20 |
1992-11-24 |
Anti-Gene Development Group |
Sequence-specific binding polymers for duplex nucleic acids
|
|
US5185444A
(en)
|
1985-03-15 |
1993-02-09 |
Anti-Gene Deveopment Group |
Uncharged morpolino-based polymers having phosphorous containing chiral intersubunit linkages
|
|
US5034506A
(en)
|
1985-03-15 |
1991-07-23 |
Anti-Gene Development Group |
Uncharged morpholino-based polymers having achiral intersubunit linkages
|
|
US5506337A
(en)
|
1985-03-15 |
1996-04-09 |
Antivirals Inc. |
Morpholino-subunit combinatorial library and method
|
|
US5591722A
(en)
|
1989-09-15 |
1997-01-07 |
Southern Research Institute |
2'-deoxy-4'-thioribonucleosides and their antiviral activity
|
|
EP0497875B1
(en)
|
1989-10-24 |
2000-03-22 |
Isis Pharmaceuticals, Inc. |
2' modified oligonucleotides
|
|
US5646265A
(en)
|
1990-01-11 |
1997-07-08 |
Isis Pharmceuticals, Inc. |
Process for the preparation of 2'-O-alkyl purine phosphoramidites
|
|
US5670633A
(en)
|
1990-01-11 |
1997-09-23 |
Isis Pharmaceuticals, Inc. |
Sugar modified oligonucleotides that detect and modulate gene expression
|
|
GB9009980D0
(en)
|
1990-05-03 |
1990-06-27 |
Amersham Int Plc |
Phosphoramidite derivatives,their preparation and the use thereof in the incorporation of reporter groups on synthetic oligonucleotides
|
|
DE69032425T2
(de)
|
1990-05-11 |
1998-11-26 |
Microprobe Corp., Bothell, Wash. |
Teststreifen zum Eintauchen für Nukleinsäure-Hybridisierungsassays und Verfahren zur kovalenten Immobilisierung von Oligonucleotiden
|
|
US6582908B2
(en)
|
1990-12-06 |
2003-06-24 |
Affymetrix, Inc. |
Oligonucleotides
|
|
US5877160A
(en)
|
1991-05-31 |
1999-03-02 |
Genta Incorporated |
Compositions and methods of treatment of androgen-associated baldness using antisense oligomers
|
|
US7517644B1
(en)
|
1991-08-23 |
2009-04-14 |
Larry J. Smith |
Method and compositions for cellular reprogramming
|
|
ES2103918T3
(es)
|
1991-10-17 |
1997-10-01 |
Ciba Geigy Ag |
Nucleosidos biciclicos, oligonucleotidos, procedimiento para su obtencion y productos intermedios.
|
|
US5359044A
(en)
|
1991-12-13 |
1994-10-25 |
Isis Pharmaceuticals |
Cyclobutyl oligonucleotide surrogates
|
|
FR2687679B1
(fr)
|
1992-02-05 |
1994-10-28 |
Centre Nat Rech Scient |
Oligothionucleotides.
|
|
EP0577558A2
(de)
|
1992-07-01 |
1994-01-05 |
Ciba-Geigy Ag |
Carbocyclische Nukleoside mit bicyclischen Ringen, Oligonukleotide daraus, Verfahren zu deren Herstellung, deren Verwendung und Zwischenproduckte
|
|
EP0673559A1
(en)
|
1992-12-14 |
1995-09-27 |
Honeywell Inc. |
Motor system with individually controlled redundant windings
|
|
WO1994018835A1
(en)
|
1993-02-19 |
1994-09-01 |
Genta Incorporated |
Treatment of androgen-associated baldness using antisense oligomers
|
|
AU6449394A
(en)
|
1993-03-30 |
1994-10-24 |
Sterling Winthrop Inc. |
Acyclic nucleoside analogs and oligonucleotide sequences containing them
|
|
US5801154A
(en)
|
1993-10-18 |
1998-09-01 |
Isis Pharmaceuticals, Inc. |
Antisense oligonucleotide modulation of multidrug resistance-associated protein
|
|
US5556956A
(en)
|
1993-11-04 |
1996-09-17 |
Board Of Regents, The University Of Texas System |
Methods and compositions relating to the androgen receptor gene and uses thereof
|
|
US5446137B1
(en)
|
1993-12-09 |
1998-10-06 |
Behringwerke Ag |
Oligonucleotides containing 4'-substituted nucleotides
|
|
US5519134A
(en)
|
1994-01-11 |
1996-05-21 |
Isis Pharmaceuticals, Inc. |
Pyrrolidine-containing monomers and oligomers
|
|
US5627053A
(en)
|
1994-03-29 |
1997-05-06 |
Ribozyme Pharmaceuticals, Inc. |
2'deoxy-2'-alkylnucleotide containing nucleic acid
|
|
US5597909A
(en)
|
1994-08-25 |
1997-01-28 |
Chiron Corporation |
Polynucleotide reagents containing modified deoxyribose moieties, and associated methods of synthesis and use
|
|
WO1997011170A1
(en)
|
1995-09-20 |
1997-03-27 |
Worcester Foundation For Biomedical Research |
Antisense oligonucleotide chemotherapy for benign hyperplasia or cancer of the prostate
|
|
US6300060B1
(en)
|
1995-11-09 |
2001-10-09 |
Dana-Farber Cancer Institute, Inc. |
Method for predicting the risk of prostate cancer morbidity and mortality
|
|
US5656408A
(en)
|
1996-04-29 |
1997-08-12 |
Xerox Corporation |
Coated carrier particles
|
|
US6489163B1
(en)
|
1996-05-08 |
2002-12-03 |
Board Of Regents, The University Of Texas System |
Ribozyme mediated inactivation of the androgen receptor
|
|
JP3756313B2
(ja)
|
1997-03-07 |
2006-03-15 |
武 今西 |
新規ビシクロヌクレオシド及びオリゴヌクレオチド類縁体
|
|
US6770748B2
(en)
|
1997-03-07 |
2004-08-03 |
Takeshi Imanishi |
Bicyclonucleoside and oligonucleotide analogue
|
|
US5994076A
(en)
|
1997-05-21 |
1999-11-30 |
Clontech Laboratories, Inc. |
Methods of assaying differential expression
|
|
DE69829760T3
(de)
|
1997-09-12 |
2016-04-14 |
Exiqon A/S |
Bi- und tri-zyklische - nukleosid, nukleotid und oligonukleotid-analoga
|
|
US6794499B2
(en)
|
1997-09-12 |
2004-09-21 |
Exiqon A/S |
Oligonucleotide analogues
|
|
US20030228597A1
(en)
|
1998-04-13 |
2003-12-11 |
Cowsert Lex M. |
Identification of genetic targets for modulation by oligonucleotides and generation of oligonucleotides for gene modulation
|
|
US6043352A
(en)
|
1998-08-07 |
2000-03-28 |
Isis Pharmaceuticals, Inc. |
2'-O-Dimethylaminoethyloxyethyl-modified oligonucleotides
|
|
EP1114179A2
(en)
|
1998-09-15 |
2001-07-11 |
Signalgene Inc. |
Marker at the androgen receptor gene for determining breast cancer susceptibility
|
|
BR0009884A
(pt)
|
1999-04-21 |
2002-01-08 |
American Home Prod |
Processos e composições para a inibição da função das sequências de polinucleotìdeos
|
|
AU776362B2
(en)
|
1999-05-04 |
2004-09-09 |
Roche Innovation Center Copenhagen A/S |
L-ribo-LNA analogues
|
|
US6525191B1
(en)
|
1999-05-11 |
2003-02-25 |
Kanda S. Ramasamy |
Conformationally constrained L-nucleosides
|
|
EP1244667B1
(en)
|
1999-12-30 |
2006-04-05 |
K.U. Leuven Research & Development |
Cyclohexene nucleic acids
|
|
US6255110B1
(en)
|
2000-01-21 |
2001-07-03 |
Isis Pharmaceuticals, Inc. |
Antisense modulation of ARA70 expression
|
|
WO2001073116A2
(en)
|
2000-03-28 |
2001-10-04 |
Signalgene Inc. |
Method for determining osteoporosis susceptibility and/or low bone density and reagents therefor
|
|
AU2001250572A1
(en)
|
2000-04-07 |
2001-10-23 |
Epigenomics Ag |
Detection of single nucleotide polymorphisms (snp's) and cytosine-methylations
|
|
US6784291B2
(en)
|
2000-05-04 |
2004-08-31 |
Avi Biopharma, Inc. |
Splice-region antisense composition and method
|
|
IL152719A0
(en)
|
2000-06-28 |
2003-06-24 |
Bristol Myers Squibb Co |
Selective androgen receptor modulators and methods for their identification
|
|
MXPA02012573A
(es)
|
2000-06-28 |
2003-05-14 |
Squibb Bristol Myers Co |
Lineas de celulas y ensayos en base a celulas para la identificacion de moduladores de receptores de androgeno.
|
|
RU2003102390A
(ru)
*
|
2000-06-28 |
2004-05-27 |
Бристол-Маерс Сквибб Компани (Us) |
Селективные модуляторы рецептора андрогена и способы их идентификации, изготовления и применения
|
|
AU2001278068A1
(en)
|
2000-07-27 |
2002-02-13 |
University Of Rochester |
Methods and compositions for predicting prostate cancer
|
|
US20020165381A1
(en)
|
2000-11-30 |
2002-11-07 |
Isabelle Ahrens-Fath |
Human androgen receptor variants
|
|
JP2002247986A
(ja)
|
2001-02-23 |
2002-09-03 |
Mitsui Chemicals Inc |
性ホルモン受容体作用評価に有用な細胞
|
|
WO2002085308A2
(en)
|
2001-04-24 |
2002-10-31 |
Epigenesis Pharmaceuticals, Inc. |
Antisense and anti-inflammatory based compositions to treat respiratory disorders
|
|
US20050159376A1
(en)
|
2002-02-20 |
2005-07-21 |
Slrna Therapeutics, Inc. |
RNA interference mediated inhibition 5-alpha reductase and androgen receptor gene expression using short interfering nucleic acid (siNA)
|
|
CA2452458A1
(en)
|
2001-07-03 |
2003-01-16 |
Isis Pharmaceuticals, Inc. |
Nuclease resistant chimeric oligonucleotides
|
|
US6680342B2
(en)
|
2001-09-20 |
2004-01-20 |
Mayo Foundation For Medical Education And Research |
Methods and compositions for inhibiting the proliferation of prostate cancer cells
|
|
FR2832154B1
(fr)
|
2001-11-09 |
2007-03-16 |
Centre Nat Rech Scient |
Oligonucleotides inhibiteurs et leur utilisation pour reprimer specifiquement un gene
|
|
US6861432B2
(en)
|
2001-11-23 |
2005-03-01 |
Schering Aktiengesellschaft |
Piperazine derivatives that destabilize androgen receptors
|
|
JP2004008140A
(ja)
|
2002-06-10 |
2004-01-15 |
Sumitomo Chem Co Ltd |
変異型アンドロゲンレセプターおよびその活性評価用細胞
|
|
WO2004011624A2
(en)
|
2002-07-31 |
2004-02-05 |
Nucleonics, Inc. |
Double stranded rna structures and constructs, and methods for generating and using the same
|
|
WO2004035765A2
(en)
|
2002-10-18 |
2004-04-29 |
Nucleonics, Inc. |
Double-stranded rna structures and constructs, and methods for generating and using the same
|
|
AU2003286757B2
(en)
|
2002-11-01 |
2009-06-04 |
Merck Sharp & Dohme Corp. |
Carbonylamino-benzimidazole derivatives as androgen receptor modulators
|
|
EP1562971B1
(en)
|
2002-11-05 |
2014-02-12 |
Isis Pharmaceuticals, Inc. |
Polycyclic sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation
|
|
AU2003295387A1
(en)
|
2002-11-05 |
2004-06-03 |
Isis Parmaceuticals, Inc. |
Modified oligonucleotides for use in rna interference
|
|
US8090542B2
(en)
|
2002-11-14 |
2012-01-03 |
Dharmacon Inc. |
Functional and hyperfunctional siRNA
|
|
US6673661B1
(en)
|
2002-12-20 |
2004-01-06 |
Taiwan Semiconductor Manufacturing Co., Ltd. |
Self-aligned method for forming dual gate thin film transistor (TFT) device
|
|
CA2512337A1
(en)
|
2003-01-03 |
2004-07-29 |
Gencia Corporation |
Sirna mediated post-transcriptional gene silencing of genes involved in alopecia
|
|
MXPA05007605A
(es)
|
2003-01-17 |
2005-09-30 |
Warner Lambert Co |
Antagonista del receptor de androgenos.
|
|
JP2004254600A
(ja)
|
2003-02-26 |
2004-09-16 |
Sumitomo Chem Co Ltd |
変異型アンドロゲンレセプターおよびその活性評価用細胞
|
|
JP2004254601A
(ja)
|
2003-02-26 |
2004-09-16 |
Sumitomo Chem Co Ltd |
変異型アンドロゲンレセプターおよびその活性評価用細胞
|
|
DE10322108B4
(de)
|
2003-05-09 |
2008-12-11 |
Bayer Schering Pharma Aktiengesellschaft |
Antiandrogene Pyrrolidine mit tumorhemmender Wirksamkeit
|
|
WO2004106356A1
(en)
|
2003-05-27 |
2004-12-09 |
Syddansk Universitet |
Functionalized nucleotide derivatives
|
|
DK1661905T3
(da)
|
2003-08-28 |
2012-07-23 |
Takeshi Imanishi |
Hidtil ukendte syntetiske nukleinsyrer af N-O-krydsbindingstype
|
|
AU2004274021B2
(en)
|
2003-09-18 |
2009-08-13 |
Isis Pharmaceuticals, Inc. |
4'-thionucleosides and oligomeric compounds
|
|
US20050164970A1
(en)
|
2003-12-22 |
2005-07-28 |
University Of Kansas Medical Center |
Method for treating prostate cancer using siRNA duplex for androgen receptor
|
|
US20050244851A1
(en)
|
2004-01-13 |
2005-11-03 |
Affymetrix, Inc. |
Methods of analysis of alternative splicing in human
|
|
JP2007523159A
(ja)
|
2004-02-20 |
2007-08-16 |
ジェネシス リサーチ アンド デベロップメント コーポレイション リミテッド |
Ｒｎａ干渉分子の標的送達
|
|
US7696241B2
(en)
|
2004-03-04 |
2010-04-13 |
Bristol-Myers Squibb Company |
Bicyclic compounds as modulators of androgen receptor function and method
|
|
AU2005248147A1
(en)
|
2004-05-11 |
2005-12-08 |
Alphagen Co., Ltd. |
Polynucleotides for causing RNA interference and method for inhibiting gene expression using the same
|
|
RU2006144863A
(ru)
|
2004-05-17 |
2008-06-27 |
Акэдиа Фармасьютикалз Инк. (Us) |
Модуляторы андрогеновых рецепторов и способ лечения заболеваний с их помощью
|
|
DE102004025881A1
(de)
|
2004-05-19 |
2006-01-05 |
Beiersdorf Ag |
Oligoribonukleotide zur Beeinflussung des Haarwachstums
|
|
CA2569419A1
(en)
|
2004-06-03 |
2005-12-22 |
Isis Pharmaceuticals, Inc. |
Double strand compositions comprising differentially modified strands for use in gene modulation
|
|
EP1791567B1
(en)
|
2004-08-10 |
2015-07-29 |
Alnylam Pharmaceuticals Inc. |
Chemically modified oligonucleotides
|
|
US20080261905A1
(en)
|
2004-11-08 |
2008-10-23 |
K.U. Leuven Research And Development |
Modified Nucleosides for Rna Interference
|
|
WO2006086345A2
(en)
|
2005-02-07 |
2006-08-17 |
The Trustees Of Columbia University In The City Of New York |
Methods to treat or prevent hormone-resistant prostate cancer using sirna specific for protocadherin-pc, or other inhibitors of protocadherin-pc expression or activity
|
|
US8912317B2
(en)
|
2005-02-11 |
2014-12-16 |
International Business Machines Corporation |
Ribonucleic acid interference molecules of Arabidopsis thaliana
|
|
US20060263798A1
(en)
|
2005-02-11 |
2006-11-23 |
International Business Machines Corporation |
System and method for identification of MicroRNA precursor sequences and corresponding mature MicroRNA sequences from genomic sequences
|
|
US8795987B2
(en)
|
2005-02-11 |
2014-08-05 |
International Business Machines Corporation |
Ribonucleic acid interference molecules of Oryza sativa
|
|
US20070213293A1
(en)
|
2005-04-08 |
2007-09-13 |
Nastech Pharmaceutical Company Inc. |
Rnai therapeutic for respiratory virus infection
|
|
US7709517B2
(en)
|
2005-05-13 |
2010-05-04 |
The Regents Of The University Of California |
Diarylhydantoin compounds
|
|
US20070111227A1
(en)
|
2005-07-28 |
2007-05-17 |
Green Pamela J |
Small regulatory RNAs and methods of use
|
|
US7700567B2
(en)
|
2005-09-29 |
2010-04-20 |
Supergen, Inc. |
Oligonucleotide analogues incorporating 5-aza-cytosine therein
|
|
CA2640171C
(en)
|
2006-01-27 |
2014-10-28 |
Isis Pharmaceuticals, Inc. |
6-modified bicyclic nucleic acid analogs
|
|
JP4961549B2
(ja)
|
2006-02-16 |
2012-06-27 |
国立大学法人愛媛大学 |
アンドロゲン受容体遺伝子に特異的なｓｉＲＮＡ
|
|
US8178503B2
(en)
|
2006-03-03 |
2012-05-15 |
International Business Machines Corporation |
Ribonucleic acid interference molecules and binding sites derived by analyzing intergenic and intronic regions of genomes
|
|
EP2656842B1
(en)
|
2006-03-27 |
2016-08-10 |
The Regents of The University of California |
Androgen receptor modulator for the treatment of prostate cancer and androgen receptor-associated diseases
|
|
JP2007282598A
(ja)
|
2006-04-19 |
2007-11-01 |
Japan Health Science Foundation |
性分化異常症診断マーカー
|
|
JP5441688B2
(ja)
|
2006-05-11 |
2014-03-12 |
アイシス ファーマシューティカルズ， インコーポレーテッド |
５’修飾二環式核酸類似体
|
|
JP4798093B2
(ja)
|
2006-08-04 |
2011-10-19 |
日産自動車株式会社 |
流体改質装置及びこれを用いた流体改質方法
|
|
AR055648A1
(es)
|
2006-09-21 |
2007-08-29 |
Gen Med Sa |
Un oligonucleotido de rna de doble cadena una composicion farmaceutica o cosmetica que lo comprende y uso del mismo enla preparacion de un medicamento para el tratamiento de enfermedades relacionadas con el metabolismo de androgenos
|
|
EP2140027B1
(en)
|
2006-12-07 |
2012-07-18 |
Novartis AG |
Non-invasive prenatal genetic screen
|
|
US7960435B2
(en)
|
2006-12-15 |
2011-06-14 |
University Of Maryland, Baltimore |
Anti-cancer agents and androgen inhibition activity compound
|
|
WO2008101157A1
(en)
|
2007-02-15 |
2008-08-21 |
Isis Pharmaceuticals, Inc. |
5'-substituted-2'-f modified nucleosides and oligomeric compounds prepared therefrom
|
|
US8461343B2
(en)
|
2007-03-27 |
2013-06-11 |
Sloan-Kettering Institute For Cancer Research |
Synthesis of thiohydantoins
|
|
EP2170917B1
(en)
|
2007-05-30 |
2012-06-27 |
Isis Pharmaceuticals, Inc. |
N-substituted-aminomethylene bridged bicyclic nucleic acid analogs
|
|
ES2386492T3
(es)
|
2007-06-08 |
2012-08-21 |
Isis Pharmaceuticals, Inc. |
Análogos de ácidos nucleicos bicíclicos carbocíclicos
|
|
CN101796062B
(zh)
|
2007-07-05 |
2014-07-30 |
Isis制药公司 |
6-双取代双环核酸类似物
|
|
MX2010003606A
(es)
*
|
2007-10-01 |
2010-07-02 |
Isis Pharmaceuticals Inc |
Modulacion antisentido de la expresion del receptor del factor de crecimiento fibroblastico 4.
|
|
WO2009067647A1
(en)
|
2007-11-21 |
2009-05-28 |
Isis Pharmaceuticals, Inc. |
Carbocyclic alpha-l-bicyclic nucleic acid analogs
|
|
US7737125B2
(en)
*
|
2007-11-26 |
2010-06-15 |
Enzon Pharamaceuticals, Inc. |
LNA antagonists targeting the androgen receptor
|
|
US8450290B2
(en)
|
2007-11-26 |
2013-05-28 |
Enzon Pharmaceuticals, Inc. |
Methods for treating androgen receptor dependent disorders including cancers
|
|
KR20100099742A
(ko)
|
2007-12-21 |
2010-09-13 |
아스트라제네카 아베 |
안드로겐 수용체 관련 병태의 치료에서 사용하기 위한 이환식 유도체
|
|
EP2265627A2
(en)
|
2008-02-07 |
2010-12-29 |
Isis Pharmaceuticals, Inc. |
Bicyclic cyclohexitol nucleic acid analogs
|
|
AU2009215168A1
(en)
|
2008-02-12 |
2009-08-20 |
Dana-Farber Cancer Institute |
Fish assay for EML4 and ALK fusion in lung cancer
|
|
FR2929292A1
(fr)
|
2008-03-28 |
2009-10-02 |
Exonhit Therapeutics S A Sa |
Procede et methodes de diagnostic de la maladie d'alzheimer
|
|
US20090282496A1
(en)
|
2008-04-04 |
2009-11-12 |
University Of Rochester Medical Center |
Androgen Receptor Related Methods for Treating Bladder Cancer
|
|
ES2836128T3
(es)
|
2008-04-16 |
2021-06-24 |
Univ Johns Hopkins |
Método para determinar variantes del receptor de andrógenos en cáncer de próstata
|
|
DK2331141T3
(en)
|
2008-08-25 |
2016-04-04 |
Excaliard Pharmaceuticals Inc |
Antisense oligonucleotides WHO IS TARGETING connective tissue, AND USES THEREOF
|
|
US8133724B2
(en)
|
2008-09-17 |
2012-03-13 |
University Of Maryland, Baltimore |
Human androgen receptor alternative splice variants as biomarkers and therapeutic targets
|
|
DK2356129T3
(da)
|
2008-09-24 |
2013-05-13 |
Isis Pharmaceuticals Inc |
Substituerede alpha-L-bicykliske nukleosider
|
|
DK2361256T3
(da)
|
2008-09-24 |
2013-07-01 |
Isis Pharmaceuticals Inc |
Cyclohexenyl-nukleinsyreanaloger
|
|
WO2010062914A1
(en)
|
2008-11-26 |
2010-06-03 |
The Johns Hopkins University |
Methods for identifying cancer risk
|
|
US8202690B2
(en)
|
2008-11-28 |
2012-06-19 |
Hisamitsu Pharmaceutical Co., Inc. |
Cancer marker and therapeutic agent for cancer
|
|
WO2011005765A1
(en)
|
2009-07-06 |
2011-01-13 |
Alnylam Pharmaceuticals, Inc. |
Bioprocessing
|
|
US20140004565A1
(en)
|
2009-07-06 |
2014-01-02 |
Alnylam Pharmaceuticals, Inc. |
Cell-based bioprocessing
|
|
HUE037389T2
(hu)
|
2010-02-16 |
2018-08-28 |
Aragon Pharmaceuticals Inc |
Androgén receptor modulátorok és alkalmazásaik
|
|
CA2791244A1
(en)
|
2010-03-08 |
2011-09-15 |
Regents Of The University Of Minnesota |
Androgen receptor isoforms and methods
|
|
WO2011113015A2
(en)
|
2010-03-12 |
2011-09-15 |
Avi Biopharma, Inc. |
Antisense modulation of nuclear hormone receptors
|
|
EP2601204B1
(en)
|
2010-04-28 |
2016-09-07 |
Ionis Pharmaceuticals, Inc. |
Modified nucleosides and oligomeric compounds prepared therefrom
|
|
JP2013530154A
(ja)
|
2010-05-28 |
2013-07-25 |
サレプタ セラピューティクス， インコーポレイテッド |
修飾されたサブユニット間結合および／または末端基を有するオリゴヌクレオチドアナログ
|
|
WO2012005898A2
(en)
|
2010-06-15 |
2012-01-12 |
Alnylam Pharmaceuticals, Inc. |
Chinese hamster ovary (cho) cell transcriptome, corresponding sirnas and uses thereof
|
|
WO2012006241A2
(en)
|
2010-07-06 |
2012-01-12 |
Dicerna Pharmaceuticals, Inc. |
Methods and compositions for the specific inhibition of androgen receptor by double-stranded rna
|
|
US20130225659A1
(en)
*
|
2010-07-19 |
2013-08-29 |
Isis Pharmaceuticals, Inc. |
Modulation of nuclear-retained rna
|
|
WO2012018881A2
(en)
|
2010-08-03 |
2012-02-09 |
Alnylam Pharmaceuticals, Inc. |
Methods and compositions for the regulation of rna
|
|
AU2011326034B2
(en)
|
2010-11-12 |
2016-02-04 |
Roche Innovation Center Copenhagen A/S |
Compositions and methods for treating androgen receptor dependent disorders including cancers
|
|
CA2822462A1
(en)
|
2010-12-20 |
2012-06-28 |
The General Hospital Corporation |
Polycomb-associated non-coding rnas
|
|
JP6177692B2
(ja)
|
2011-02-02 |
2017-08-09 |
エクスカリアード・ファーマシューティカルズ，インク |
結合組織増殖因子（ｃｔｇｆ）をターゲティングするアンチセンス化合物を用いた、ケロイドまたは肥厚性瘢痕の治療法
|
|
EP3467109A1
(en)
|
2011-02-08 |
2019-04-10 |
Ionis Pharmaceuticals, Inc. |
Oligomeric compounds comprising bicyclic nucleotides and uses thereof
|
|
US20140031257A1
(en)
*
|
2011-03-10 |
2014-01-30 |
Oslo Universitetssykehus Hf |
Methods and biomarkers for detection of gastrointestinal cancers
|
|
US10023861B2
(en)
|
2011-08-29 |
2018-07-17 |
Ionis Pharmaceuticals, Inc. |
Oligomer-conjugate complexes and their use
|
|
EP2812342B1
(en)
|
2012-02-08 |
2017-11-15 |
Ionis Pharmaceuticals, Inc. |
Modulation of rna by repeat targeting
|
|
US9778706B2
(en)
|
2012-02-24 |
2017-10-03 |
Blackberry Limited |
Peekable user interface on a portable electronic device
|
|
US9984408B1
(en)
|
2012-05-30 |
2018-05-29 |
Amazon Technologies, Inc. |
Method, medium, and system for live video cooperative shopping
|
|
US9175291B2
(en)
*
|
2012-10-11 |
2015-11-03 |
Isis Pharmaceuticals Inc. |
Modulation of androgen receptor expression
|